124 related articles for article (PubMed ID: 38422890)
1. Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data.
Isayeva U; Manchia M; Collu R; Primavera D; Deriu L; Caboni E; Iaselli NM; Sundas D; Tusconi M; Pinna F; Paribello P; Scherma M; Pisanu C; Meloni A; Zai CC; Congiu D; Squassina A; Fratta W; Fadda P; Carpiniello B
Schizophr Res; 2024 Apr; 266():197-204. PubMed ID: 38422890
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.
Primavera D; Manchia M; Deriu L; Tusconi M; Collu R; Scherma M; Fadda P; Fratta W; Carpiniello B
BMJ Open; 2017 May; 7(5):e014938. PubMed ID: 28550022
[TBL] [Abstract][Full Text] [Related]
3. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
[TBL] [Abstract][Full Text] [Related]
4. The role of BDNF in the pathophysiology and treatment of schizophrenia.
Favalli G; Li J; Belmonte-de-Abreu P; Wong AH; Daskalakis ZJ
J Psychiatr Res; 2012 Jan; 46(1):1-11. PubMed ID: 22030467
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia.
Chen L; Li XS; Zheng GE; Xie GJ; Cheng Y
Neurosci Lett; 2020 Jan; 714():134618. PubMed ID: 31711978
[TBL] [Abstract][Full Text] [Related]
6. Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders.
Manchia M; Isayeva U; Collu R; Primavera D; Deriu L; Caboni E; Iaselli MN; Sundas D; Tusconi M; Pinna F; Paribello P; Scherma M; Pisanu C; Meloni A; Zai CC; Congiu D; Squassina A; Fratta W; Fadda P; Carpiniello B
Brain Sci; 2022 Dec; 12(12):. PubMed ID: 36552127
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study.
Li S; Chen D; Xiu M; Li J; Zhang XY
J Psychiatr Res; 2021 Feb; 134():39-47. PubMed ID: 33360223
[TBL] [Abstract][Full Text] [Related]
8. Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients.
Isayeva U; Manchia M; Collu R; Primavera D; Deriu L; Caboni E; Iaselli N; Sundas D; Tusconi M; Pinna F; Paribello P; Scherma M; Pisanu C; Meloni A; Zai CC; Congiu D; Squassina A; Fratta W; Fadda P; Carpiniello B
Eur Psychiatry; 2022 Oct; 65(1):e71. PubMed ID: 36281033
[TBL] [Abstract][Full Text] [Related]
9. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
10. Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study.
Kirli U; Binbay T; Drukker M; Elbi H; Kayahan B; Gökçelli DK; Özkınay F; Onay H; Alptekin K; van Os J
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):113-121. PubMed ID: 29785763
[TBL] [Abstract][Full Text] [Related]
11. BDNF Val66Met variants and brain volume changes in non-affective psychosis patients and healthy controls: a 3 year follow-up study.
Suárez-Pinilla P; Roiz-Santiáñez R; de la Foz VO; Mata I; Fañanas L; Brambilla P; Ruíz-Pérez E; Crespo-Facorro B
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():201-6. PubMed ID: 23748016
[TBL] [Abstract][Full Text] [Related]
12. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
Pries LK; Dal Ferro GA; van Os J; Delespaul P; Kenis G; Lin BD; Luykx JJ; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Şahin Cankurtaran E; Ulusoy Kaymak S; Mihaljevic MM; Andric Petrovic S; Mirjanic T; Bernardo M; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Can Saka M; ; Arango C; O'Donovan M; Tosato S; Rutten BPF; Guloksuz S
Epidemiol Psychiatr Sci; 2020 Nov; 29():e182. PubMed ID: 33200977
[TBL] [Abstract][Full Text] [Related]
13. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
Bonaccorso S; Sodhi M; Li J; Bobo WV; Chen Y; Tumuklu M; Theleritis C; Jayathilake K; Meltzer HY
Bipolar Disord; 2015 Aug; 17(5):528-35. PubMed ID: 25874530
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
[No Abstract] [Full Text] [Related]
15. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients.
Chung S; Chung HY; Jung J; Chang JK; Hong JP
Compr Psychiatry; 2010; 51(4):367-72. PubMed ID: 20579509
[TBL] [Abstract][Full Text] [Related]
16. Clinical profile in schizophrenia and schizoaffective spectrum: relation with unconjugated bilirubin in a prospective and controlled study with psychopathological and psychosocial variables.
Gama Marques J; Ouakinin S
CNS Spectr; 2020 Dec; 25(6):782-789. PubMed ID: 31852561
[TBL] [Abstract][Full Text] [Related]
17. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
[TBL] [Abstract][Full Text] [Related]
18. Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia.
Xiu MH; Wang DM; Du XD; Chen N; Tan SP; Tan YL; Yang F; Cho RY; Zhang XY
Psychoneuroendocrinology; 2019 Oct; 108():110-117. PubMed ID: 31255950
[TBL] [Abstract][Full Text] [Related]
19. [The Association between the Extended Psychosis Phenotype and COMT val158met and BDNF val66met polymorphisms].
Binbay T; Kırlı U; Mısır E; Elbi H; Kayahan B; Onay H; Özkınay F; Drukker M; Os JV; Alptekin K
Turk Psikiyatri Derg; 2018; 29(4):221-228. PubMed ID: 30887472
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders.
Zai CC; Manchia M; Sønderby IE; Yilmaz Z; De Luca V; Tiwari AK; Squassina A; Zai GC; Shaikh SA; Strauss J; King N; Le Foll B; Kaplan AS; Finseth PI; Vaaler AE; Djurovic S; Andreassen OA; Vincent JB; Kennedy JL
World J Biol Psychiatry; 2015 Apr; 16(3):171-9. PubMed ID: 25264289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
